Sign in

NCT07414446Recruiting

Non-Invasive Detection of Pulmonary Right-to-Left Shunts Using the SONAS Ultrasound Device

Novel Approach For The Non-Invasive Detection of Pulmonary Right-to-Left Shunts

Source: ClinicalTrials.gov · Last updated 17 Feb 2026

Brief summary (registry, in English)

The goal of this clinical trial is to learn how well the SONAS ultrasound device can detect right-to-left shunts of adults with hereditary hemorrhagic telangiectasia (HHT) who are already scheduled for a contrast bubble echocardiogram (TTCE). The main questions it aims to answer are: 1. How accurately does SONAS detect right-to-left shunts compared to the standard TTCE test? 2. Can SONAS results help tell the difference between shunts in the heart and shunts in the lungs? Participants will wear a headband with the SONAS device on the head while they undergo their routine TTCE bubble test. They will receive the usual contrast (agitated saline) through a vein, and both SONAS and TTCE signals will be recorded at the same time. There will be one examination in rest, and one during a breathing exercise (the Valsalva manoeuvre).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
3 Feb 2026
Start date
7 Jan 2026
Primary completion date
1 Apr 2026
Lead sponsor
St. Antonius Hospital
Diseases
Stroke
NCT number
NCT07414446

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 7 Jan 2026 to the primary completion date, 1 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with known metal skull implants in the anatomical area of the temporal / parietal bones, or with anatomical formation of the head or ear tha may interfere with proper headset placement.

Other illness

  • Patients with known allergies or reactions to parabens, which are present in the gel pad material of the applied part.

Other

  • Pregnancy or breastfeeding.
  • Known or suspected fracture(s) of the temporal / parietal skull bones, or with open skin injuries in the anatomical area of the temporal / parietal lobes.

Who the study is looking for

  • Age 18 years or older.
  • Suspected or confirmed hereditary hemorrhagic telangiectasia (HHT).
  • Incidentally: Patients who have experienced cryptogenic stroke

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
St. Antonius Hospital
Coordinator of this site? Confirm its status
NieuwegeinNetherlandsRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.